These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30563358)

  • 41. Determinants of preventable stroke-Ankara ACROSS stroke preventability study.
    Erkent I; Topcuoglu MA; Sorgun MH; Batur Caglayan HZ; Togay Isikay C; Nazliel B; Arsava EM
    J Stroke Cerebrovasc Dis; 2020 Jul; 29(7):104825. PubMed ID: 32362556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.
    Law M; Wald N; Morris J
    Health Technol Assess; 2003; 7(31):1-94. PubMed ID: 14604498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relative importance of benefits and risks associated with antithrombotic therapies for acute coronary syndrome: patient and physician perspectives.
    Yuan Z; Levitan B; Burton P; Poulos C; Brett Hauber A; Berlin JA
    Curr Med Res Opin; 2014 Sep; 30(9):1733-41. PubMed ID: 24827068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspirin for Primary Prevention.
    Richman IB; Owens DK
    Med Clin North Am; 2017 Jul; 101(4):713-724. PubMed ID: 28577622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vorapaxar: A Protease-Activated Receptor Antagonist for the Prevention of Thrombotic Events.
    Lam S; Tran T
    Cardiol Rev; 2015; 23(5):261-7. PubMed ID: 25923910
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early intervention and prevention of myocardial infarction.
    Pais PS
    J Hypertens Suppl; 2006 Apr; 24(2):S25-30. PubMed ID: 16601557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physical Activity Frequency and the Risk of Stroke: A Nationwide Cohort Study in Korea.
    Jeong HG; Kim DY; Kang DW; Kim BJ; Kim CK; Kim Y; Yang W; Park ES; Lee SH
    J Am Heart Assoc; 2017 Aug; 6(9):. PubMed ID: 28855168
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prevention of arteriosclerosis. Importance of the treatment of arterial hypertension].
    Bönner G; Gysan DB; Sauer G
    Z Kardiol; 2005; 94 Suppl 3():III/56-65. PubMed ID: 16258793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
    Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
    Antithrombotic Trialists' Collaboration
    BMJ; 2002 Jan; 324(7329):71-86. PubMed ID: 11786451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative effectiveness of cardioprotective drugs in elderly individuals with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Int J Clin Pract; 2015 Mar; 69(3):305-12. PubMed ID: 25359240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Challenges for the prevention of primary and secondary stroke: the importance of lowering blood pressure and total cardiovascular risk.
    Chalmers J; Chapman N
    Blood Press; 2001; 10(5-6):344-51. PubMed ID: 11822538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE).
    Mendis S; Abegunde D; Yusuf S; Ebrahim S; Shaper G; Ghannem H; Shengelia B
    Bull World Health Organ; 2005 Nov; 83(11):820-9. PubMed ID: 16302038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case-control study of second-line therapies for type 2 diabetes in combination with metformin and the comparative risks of myocardial infarction and stroke.
    Floyd JS; Wiggins KL; Sitlani CM; Flory JH; Dublin S; Smith NL; Heckbert SR; Psaty BM
    Diabetes Obes Metab; 2015 Dec; 17(12):1194-7. PubMed ID: 26179389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aspirin for Primary and Secondary Prevention of Cardiovascular Disease.
    Godley RW; Hernandez-Vila E
    Tex Heart Inst J; 2016 Aug; 43(4):318-9. PubMed ID: 27547141
    [No Abstract]   [Full Text] [Related]  

  • 57. Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction.
    Kaplan RC; Heckbert SR; Furberg CD; Psaty BM
    J Clin Epidemiol; 2002 Jul; 55(7):654-64. PubMed ID: 12160913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspirin for primary prevention of myocardial infarction: what is the evidence?
    Kappagoda T; Amsterdam E
    J Cardiopulm Rehabil Prev; 2012; 32(1):1-8. PubMed ID: 21946421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.
    Stevens W; Peneva D; Li JZ; Liu LZ; Liu G; Gao R; Lakdawalla DN
    BMC Health Serv Res; 2016 May; 16():175. PubMed ID: 27165638
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.